5.6K(top 5%)
articles
174.6K(top 4%)
citations
1,168(top 5%)
★★ articles
148(top 2%)
★★★ articles
3.6(top 8%)
Avg IF
169(top 3%)
H-Index
295(top 3%)
G-Index
1,032
journals

Most Cited Articles of George Institute for Global Health in 2020

TitleJournalYearCitations
Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease StudyLancet, The20201.1K
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 StudyJournal of the American College of Cardiology2020922
Dapagliflozin in Patients with Chronic Kidney DiseaseNew England Journal of Medicine2020865
Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-AnalysisJournal of Clinical Medicine2020282
2020 International Society of Hypertension global hypertension practice guidelinesJournal of Hypertension2020158
Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017JAMA - Journal of the American Medical Association2020136
Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysisBMJ, The2020124
Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines AgencyAmerican Journal of Kidney Diseases2020124
Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HFCirculation2020122
Personal protective equipment and intensive care unit healthcare worker safety in the COVID-19 era (PPE-SAFE): An international surveyJournal of Critical Care2020110
The impact of 2019 novel coronavirus on heart injury: A Systematic review and Meta-analysisProgress in Cardiovascular Diseases2020110
Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modelling studyThe Lancet Global Health2020109
Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort studyLancet Diabetes and Endocrinology,the2020109
Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceKidney International2020106
Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trialNephrology Dialysis Transplantation2020105
May Measurement Month 2019: The Global Blood Pressure Screening Campaign of the International Society of HypertensionHypertension202099
Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-AnalysisJournal of the American Heart Association202097
Impact of COVID-19 Outbreak on Healthcare Workers in Italy: Results from a National E-SurveyJournal of Community Health202092
Effect of dose and duration of reduction in dietary sodium on blood pressure levels: systematic review and meta-analysis of randomised trialsBMJ, The202083
Estimated Health Benefits, Costs, and Cost-Effectiveness of Eliminating Industrial Trans-Fatty acids in AustraliaCurrent Developments in Nutrition202078
Where are the women? Gender inequalities in COVID-19 research authorshipBMJ Global Health202076
Association between HTLV-1 infection and adverse health outcomes: a systematic review and meta-analysis of epidemiological studiesLancet Infectious Diseases, The202071
Women's Participation in Cardiovascular Clinical Trials From 2010 to 2017Circulation202069
Psychological impact of COVID-19 on ophthalmologists-in-training and practising ophthalmologists in IndiaIndian Journal of Ophthalmology202069
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HFCirculation202068